NYSE · Healthcare
AVANOS MEDICAL, INC. (AVNS)
As-reported financials and recent SEC filings for AVANOS MEDICAL, INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$701.2M
Net income
$-72.9M
Net margin
-10.4%
Diluted EPS
$-1.57
ROE
-9.4%
P/E (TTM)
—
Market cap
$1.17B
Debt / equity
0.1×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $701.2M | $687.8M | $673.3M | $684.1M | $587.0M |
| Gross profit | $353.9M | $381.3M | $379.7M | $394.2M | $299.2M |
| Operating income | $-61.6M | $-396.2M | $4.2M | $35.5M | $-39.0M |
| Net income | $-72.9M | $-392.1M | $-61.8M | $50.5M | $6.3M |
| Diluted EPS | $-1.57 | $-8.53 | $-1.32 | $1.07 | $0.13 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
DEFM14A2026-06-10
View on EDGAR →SD2026-06-01
View on EDGAR →PREM14A2026-05-29
View on EDGAR →SCHEDULE 13G/A2026-05-15
View on EDGAR →42026-05-12
View on EDGAR →42026-05-12
View on EDGAR →42026-05-12
View on EDGAR →42026-05-12
View on EDGAR →Go deeper on AVNS
Search AVANOS MEDICAL, INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.